Skip to main content
  • Meet our 2018-2019 T32 Fellows

    Meet our 2019-2020 T32 Fellows

APPLY NOW

Please Note: Applications are reviewed annually between January - March for the upcoming training periods. Training periods currently run from July 1 – June 30


Meet our 2019-2020 T32 Fellows

Emily Deischel

Emily Deichsel, PhD

Emily is a post-doctoral fellow interested in pediatric acute infections, maternal health, and childhood growth among vulnerability populations.

For her fellowship Emily will be working with mentor Karen Kotloff, MD, Professor of Pediatrics, Head of Pediatric Infectious Disease and Tropical Medicine and Associate Director of CVD on a large randomized trial titled “Sauver avec l’AzithromyciNe en Traitant les femmes Enceintes et les enfants (SANTE).” The trial tests efficacy of oral azithromycin delivered in pregnancy and early infancy to prevent stillbirth and infant mortality in Mali, West Africa. Her T32 project will assess the impact of co-administration of azithromycin with routine vaccinations on vaccine immune response in infants enrolled in the parent trial.

Emily received her PhD in Epidemiology from University of Washington School of Public Health, an MPH from University of California, Los Angeles, and a BA in chemistry from Lewis & Clark College.

 


Meagan Deming, MD, PhD

Meagan Deming, MD, PhD

From 2015-2017, Meagan was an internal medicine resident here at the University of Maryland Medical Center. She is currently completing and Infectious Disease Fellow at the University of Maryland Medical Center.

The focus of Meagan’s T32 will be to expand the role of therapeutic vaccinology in chronic hepatitis B. She will develop expertise in cohort building, novel viral immunology assays, and animal model studies with a specific focus on vaccinology. Her mentors include Marcelo Sztein, MD, Professor of Pediatrics Associate Director for Immunologic Studies and Associate Director of the CVD and Shyamasundaran Kottilil, MBBS, PhD, Director, Institute of Human Virology (IHV) Division of Clinical Care and Research, Director, IHV Clinical Research Unit, Chief, Division of Infectious Diseases, UMSOM Department of Medicine.

Meagan received her MD/PhD at the University of North Carolina Chapel Hill where she studied SARS-coronavirus. Now in the ABIM research track for her internal medicine residency and infectious disease fellowship, she is working with Dr. Kotiilil studying the mechanisms by which Hepatitis B virus circumvents humoral immunity in an effort to expand the role of therapeutic vaccinology for HBV. 


Amanda Driscoll, PhD

Amanda Driscoll, PhD

Amanda has devoted her early career to the study of vaccine-preventable diseases. She served as the Coordinator of the Pneumonia Etiology Research for Child Health (PERCH) study, a large and complex multicenter epidemiologic study of the etiology and outcomes of pneumonia among children 1-59 months living in low- and middle-income countries.

Her experience on PERCH motivated her to pursue a PhD in Epidemiology, which she completed in February 2018. Her doctoral research focused on the prevention of respiratory syncytial virus (RSV) using monoclonal antibody in Native American infants. She has particular interest in microbiology and molecular methods. Her career aspirations are focused on an academic position as an epidemiologist studying the epidemiology and prevention of infectious diseases among children in less developed countries.

Amanda's mentorKaren Kotloff, MD, Professor of Pediatrics, Head of Pediatric Infectious Diseases and Tropical Medicine, and Associate Director CVD, is also involved in PERCH.

Amanda received her PhD in International Health Global Disease Epidemiology and Control from Johns Hopkins School of Public Health, a Masters of Health Sciences International Health Global Disease Epidemiology and Control from Johns Hopkins, and her BS in Environmental Sciences from the College of Natural Resources University of California at Berkeley.


Rob McCann, PhD

Rob McCann, PhD

Rob joined the CVD as a Postdoctoral Fellow in April 2019. He will be evaluating the impact of the RTS,S malaria vaccine pilot program on malaria transmission in Malawi, working under the mentorship of Dr. Miriam Laufer, Professor of Pediatrics, Medicine, Epidemiology and Public Health.

Rob received his BS in Biology from the University of North Dakota and his PhD in Entomology, Ecology, Evolutionary Biology and Behavior from Michigan State University. He previously worked as a Postdoctoral Researcher for Wageningen University (Netherlands), studying the effects of community-based, integrated vector control tools on malaria transmission and burden in Malawi.

 


CVD's T32 Program

Vaccines are one of the most cost-effective approaches in preventive medicine. The National Research Service Award T32 training grant is a unique opportunity designed to prepare MDs, PhDs, or those with equivalent degrees, for careers in vaccinology. Each T32 fellow selects the laboratory research track, clinical track, or combined laboratory and clinical track. The program offers all trainees broad exposure to both laboratory and clinical trial phases of vaccinology.

Program Administration

Executive Committee

Individuals interested in fellowship opportunities are encouraged to contact individual faculty.

Trainee Application Process

Eligibility /Qualifications:

Vaccinology Trainees will receive:

How to Apply:

Fill out the Application form...

Apply Now

If you do not meet the eligibility requirements for the T32, but would like to be considered for other post-doc training opportunities, please submit your CV to cvd_training@som.umaryland.edu.

For More Information:‌

Center for Vaccine Development and Global Health
University of Maryland School of Medicine
685 W. Baltimore Street, Room 480
Baltimore, MD 21201
+1 (410) 706-5328
CVDtraining@som.umaryland.edu